Shares outstanding · 2011–2025
Travere Therapeutics shares outstanding
92.2M+5.5% · FY2025
Travere Therapeutics (TVTX) reported 92.2M in shares outstanding for fiscal 2025, +5.5% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252026-02-13 | 92.2M | +5.5% | Open → |
| FY20242024-12-31 | 87.5M | +16.0% | Open → |
| FY20232023-12-31 | 75.4M | +17.2% | Open → |
| FY20222022-12-31 | 64.3M | +2.9% | Open → |
| FY20212021-12-31 | 62.5M | +19.6% | Open → |
| FY20202020-12-31 | 52.2M | +21.3% | Open → |
| FY20192019-12-31 | 43.1M | +4.1% | Open → |
| FY20182018-12-31 | 41.4M | +5.1% | Open → |
| FY20172017-12-31 | 39.4M | +3.9% | Open → |
| FY20162016-12-31 | 37.9M | +4.0% | Open → |
| FY20152015-12-31 | 36.5M | +40.0% | Open → |
| FY20142014-12-31 | 26.0M | +41.4% | Open → |
| FY20132013-12-31 | 18.4M | +105.7% | Open → |
| FY20122012-12-31 | 9.0M | +833.4% | Open → |
| FY20112011-11-30 | 959,127 | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +38.6%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Travere Therapeutics shares outstanding |url=https://companiesranked.com/en/company/travere-therapeutics/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Travere Therapeutics shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/travere-therapeutics/shares-outstandingBibTeX
@misc{companiesranked-en-company-travere-therapeutics-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Travere Therapeutics shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/travere-therapeutics/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001438533-26-000014 · February 19, 2026
{{cite web |title=Travere Therapeutics shares outstanding — 10-K (0001438533-26-000014) |url=https://www.sec.gov/Archives/edgar/data/1438533/000143853326000014/tvtx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-19}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.